RESUMEN
ABSTRACT: To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) in photorefractive keratectomy (PRK) versus Mitomycin C (MMC).This is a comparative, longitudinal and retrospective case-control study (MMC vs PRGF), in patients with a spherical correction from -0.25 to -8.00 D and cylinder correction from -0.25 to -3.00. The uncorrected distance visual acuity (UDVA), refractive efficacy and safety indices, and changes in endothelial cell density were evaluated. The predictability was assessed with the postoperative manifest spherical equivalent.Forty-four patients (72 eyes) were treated with MMC and twenty-five patients (45 eyes) with PRGF. The final UDVA (LogMar) in MMC was 0.029â±â0.065 and in PRGF it was 0.028â±â0.048 (pâ=â0.383). The efficacy index for MMC was 0.98â±â0.10 and 1.10â±â0.46 for patients treated with PRGF (pâ=â0.062). The safety index for MMC was 1.03â±â0.11 and 1.12â±â0.46 (pâ=â0.158) for PRGF group. The change percentage of endothelial cell density was 0.9â±â11.6 for MMC and 4.3â±â13.1 for PRGF (pâ=â0.593). The predictability for MMC was 92.1% and for the PRGF was 91.9% (pâ=â0.976). Hyperemia, eye pain and superficial keratitis were observed in 11.1% of the MMC group; no adverse events were observed with the PRGF.The use of PRGF in PRK surgery is as effective as MMC. The PRGF shows a better safety profile than MMC for its intraoperative use in PRK.
Asunto(s)
Transfusión de Sangre Autóloga/métodos , Opacidad de la Córnea/prevención & control , Péptidos y Proteínas de Señalización Intercelular/administración & dosificación , Queratectomía Fotorrefractiva , Complicaciones Posoperatorias/prevención & control , Adulto , Anciano , Antibióticos Antineoplásicos/uso terapéutico , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Mitomicina/uso terapéutico , Soluciones Oftálmicas , Estudios Retrospectivos , Adulto JovenRESUMEN
A new in vitro human corneal epithelial model (QobuR) obtained from normal limbal tissue has been developed to study ocular irritancy of different ophthalmic compounded drugs. Phenotypical characterization and trans-epithelial electrical resistance (TEER) of QobuR revealed essential similarities compared with a native human cornea, displaying functional markers and TEER values near 1500â¯Ωcm2 at day 7th of cellular differentiation. Using this model, ocular irritancy and barrier integrity alterations were evaluated using MTT reaction and variations in TEER. We found that some of the Non-Irritant products evaluated still damage the corneal epithelial integrity and current protocols for ocular irritancy should therefore include a barrier integrity evaluation. Moreover, in order to comprehensively evaluate corneal permeability of the active ingredients, we propose the use of QobuR as an all-in-one alternative method for evaluating ocular irritancy, barrier disruptions and permeability rates of topically applied ocular drugs to improve current in vitro drug testing procedures.